Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Cortisol suppression impairs retrieval of emotional memory and changes its neural correlates immediately and four days post-treatment
    Published on 2026-07-23
    5 days ago
  • Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling
    Published on 2026-07-23
    5 days ago
  • Cool but not harmless: synthetic cooling agents enhance nicotine reinforcement via the mesolimbic dopamine system
    Published on 2026-07-23
    5 days ago
  • Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder
    Published on 2026-07-21
    7 days ago
  • Restoring prefrontal function with dopaminergic enhancement of memory updating in addiction
    Published on 2026-07-21
    7 days ago
  • Ketamine-induced analgesia and dissociation show distinct behavioral and neural correlates
    Published on 2026-07-20
    1 week ago
  • Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia
    Published on 2026-07-18
    1 week ago
1 2 3 … 143 Next »
Journal of Psychopharmacology
  • Genetic background and sex moderate the effects of adolescent nicotine exposure on adult functional neural circuits and behavior
    Published on 2026-07-24
    3 days ago
  • No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study
    Published on 2026-07-23
    4 days ago
  • Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder
    Published on 2026-07-16
    2 weeks ago
  • The increasing use of cognitive enhancing drugs by those with ADHD and neurotypical individuals: Societal demands, lifestyle preferences, and ethical issues
    Published on 2026-07-15
    2 weeks ago
  • Acute behavioural effects of low-dose cannabidiol: A randomised crossover trial in healthy volunteers
    Published on 2026-07-15
    2 weeks ago
  • Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology
    Published on 2026-07-13
    2 weeks ago
  • Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression
    Published on 2026-07-09
    3 weeks ago
1 2 3 … 150 Next »
European Neuropsychopharmacology
  • The impact of anhedonia on physical health and somatic diseases: an exploratory literature review
    Published on 2026-07-20
    1 week ago
  • Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report
    Published on 2026-07-18
    1 week ago
  • Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour
    Published on 2026-07-18
    1 week ago
  • The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity
    Published on 2026-07-12
    2 weeks ago
  • Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD
    Published on 2026-07-08
    3 weeks ago
  • Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder
    Published on 2026-07-08
    3 weeks ago
  • Corrigendum to “Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults” [European Neuropsychopharmacology, 112, 112887]
    Published on 2026-07-08
    3 weeks ago
1 2 3 … 168 Next »

   Pharma Pub